Search filters

List of works by Arlene O Siefker-Radtke

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results

scientific article

A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents

scientific article

A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.

scientific article

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

scientific article published in 2023

Bladder cancer: narrowing the gap between evidence and practice

scientific article

Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?

scientific article

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

scientific article published in August 2004

Focus on bladder cancer

scientific article published in August 2004

Frequent truncating mutations of STAG2 in bladder cancer

scientific article published on 13 October 2013

Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study

scientific article published on 23 December 2015

Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.

scientific article

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.

scientific article published on 14 August 2012

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

scientific article

Inhibition of inducible heat shock protein-70 (hsp72) enhances bortezomib-induced cell death in human bladder cancer cells

scientific article (publication date: 2013)

Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapy

scientific article published on December 2009

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use

scientific article published on 25 August 2016

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients

scientific article published on July 2007

Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression

scientific article published on July 2010

Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience

scientific article

NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.

scientific article published on October 2016

National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer

scientific article published on 25 July 2016

Neoadjuvant chemotherapy for bladder cancer

scientific article published on November 2003

Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma

scientific article published on 13 March 2014

Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.

scientific article published on 17 April 2012

Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience

scientific article published on August 2007

Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.

scientific article published on 09 October 2008

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors

scientific article published on 10 April 2007

PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer

scientific article published on 17 September 2020

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience

scientific article

Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy ⬇️

scientific article published on February 26, 2011

Perioperative chemotherapy for upper tract urothelial cancer

scientific article published on 10 April 2012

Phase I trial of sunitinib and temsirolimus in metastatic renal cell carcinoma

scientific article

Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer

scientific article published on 04 May 2009

Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis

scientific article

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

scientific article

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

scientific article published on December 2009

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer

scientific article

Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience ⬇️

scientific article published on 08 October 2010

Systemic chemotherapy options for metastatic bladder cancer

scientific article published on June 2006

The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder

scientific article published on 22 July 2010

The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.

scientific article published on 13 December 2012

The role of radical cystectomy in patients with clinical T4b bladder cancer

scientific article

Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease

scientific article published on 4 April 2016

Urachal adenocarcinoma: a clinician's guide for treatment

scientific article

Urachal carcinoma: a pathologic and clinical study of 46 cases

scientific article published on 12 August 2015

Urachal carcinoma: surgical and chemotherapeutic options

scientific article published on December 2006

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

scientific article

p63 expression correlates with sensitivity to the Eg5 inhibitor ZD4877 in bladder cancer cells

scientific article published on May 2012

p63 expression defines a lethal subset of muscle-invasive bladder cancers

scientific article

Paulina is supported by:

About Paulina

Help